HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 288/2/F399    most recent 00195.2004v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (27) Citing Articles via Google Scholar Google Scholar Articles by Mankhey, R. W. Articles by Maric, C. Search for Related Content PubMed PubMed Citation Articles by Mankhey, R. W. Articles by Maric, C.

17-Estradiol replacement improves renal function and pathology associated with diabetic nephropathy

Department of ¹Medicine and ²Center for the Study of Sex Differences: in Health, Aging and Disease, Georgetown University Medical Center, Washington, District of Columbia

Submitted 27 May 2004 ; accepted in final form 23 September 2004

The protective factor of female gender appears to be lost in diabetes; the incidence of diabetes and its complications, including diabetic nephropathy, are equal in women and men. This study examined the effects of estrogen deficiency by ovariectomy (OVX) and replacement with 17-estradiol (OVX+E₂) on renal function and pathology in the nondiabetic (ND) and streptozotocin (STZ)-induced diabetic (D) rat kidneys for 12 wk. Diabetes was associated with an increase in urine albumin excretion (UAE; ND, 0.39 ± 0.03; D, 5.9 ± 0.8 mg/day; P < 0.001), decrease in creatinine clearance (CrCl; ND, 0.69 ± 0.03; D, 0.43 ± 0.09 mg·min^–1·100 g body wt^–1; P < 0.05), increase in the index of glomerulosclerosis [GSI; ND, 0.01 ± 0.01; D, 0.15 ± 0.04 arbitrary units (AU); P < 0.01], tubulointerstitial fibrosis (TIFI; ND, 0.04 ± 0.04; D, 0.68 ± 0.2 AU; P < 0.01), and transforming growth factor- (TGF-) protein expression (ND, 0.61 ± 0.02; D, 1.25 ± 0.07 AU; P < 0.01). In the D group, the severity of these changes was augmented with OVX (UAE, 8.1 ± 0.6 mg/day; CrCl, 0.40 ± 0.04 mg·min^–1·100 g body wt^–1; GSI, 0.29 ± 0.04 AU; TIFI, 0.90 ± 0.06 AU; TGF-, 1.26 ± 0.10 AU), whereas E₂ replacement attenuated these changes (UAE, 6.3 ± 0.8 mg/day; CrCl, 0.66 ± 0.03 mg·min^–1·100 g body wt^–1; GSI, 0.06 ± 0.02 AU; TIFI, 0.36 ± 0.08 AU; TGF-, 0.57 ± 0.08 AU). We conclude that E₂ deficiency increases the severity of renal disease in a diabetic animal model and that E₂ replacement is renoprotective by attenuating the decline in renal function and pathology associated with diabetes.

diabetes; kidney; estrogen; extracellular matrix; fibrosis

This article has been cited by other articles:

				Q. Xu, A. Prabhu, S. Xu, M. B. Manigrasso, and C. Maric Dose-dependent effects of dihydrotestosterone in the streptozotocin-induced diabetic rat kidney Am J Physiol Renal Physiol, August 1, 2009; 297(2): F307 - F315. [Abstract] [Full Text] [PDF]

				C. Maric Sex, diabetes and the kidney Am J Physiol Renal Physiol, April 1, 2009; 296(4): F680 - F688. [Abstract] [Full Text] [PDF]

				J. C. Sullivan Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1220 - R1226. [Abstract] [Full Text] [PDF]

				Q. Xu, C. C. Wells, J. H. Garman, L. Asico, C. S. Escano, and C. Maric Imbalance in Sex Hormone Levels Exacerbates Diabetic Renal Disease Hypertension, April 1, 2008; 51(4): 1218 - 1224. [Abstract] [Full Text] [PDF]

				R. Iliescu and J. F. Reckelhoff Sex and the Kidney Hypertension, April 1, 2008; 51(4): 1000 - 1001. [Full Text] [PDF]

				A. Dixon and C. Maric 17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1678 - F1690. [Abstract] [Full Text] [PDF]

				S. Tiwari, S. Riazi, and C. A. Ecelbarger Insulin's impact on renal sodium transport and blood pressure in health, obesity, and diabetes Am J Physiol Renal Physiol, October 1, 2007; 293(4): F974 - F984. [Abstract] [Full Text] [PDF]

				L. M. Yamaleyeva, K. D. Pendergrass, N. T. Pirro, P. E. Gallagher, L. Groban, and M. C. Chappell Ovariectomy is protective against renal injury in the high-salt-fed older mRen2.Lewis rat Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2064 - H2071. [Abstract] [Full Text] [PDF]

				M. Keck, M. J. Romero-Aleshire, Q. Cai, P. B. Hoyer, and H. L. Brooks Hormonal status affects the progression of STZ-induced diabetes and diabetic renal damage in the VCD mouse model of menopause Am J Physiol Renal Physiol, July 1, 2007; 293(1): F193 - F199. [Abstract] [Full Text] [PDF]

				J. Sun, K. Devish, W. J. Langer, P. K. Carmines, and P. H. Lane Testosterone treatment promotes tubular damage in experimental diabetes in prepubertal rats Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1681 - F1690. [Abstract] [Full Text] [PDF]

				P. R. R. Gangula, W. L. Maner, M.-A. Micci, R. E. Garfield, and P. J. Pasricha Diabetes induces sex-dependent changes in neuronal nitric oxide synthase dimerization and function in the rat gastric antrum Am J Physiol Gastrointest Liver Physiol, March 1, 2007; 292(3): G725 - G733. [Abstract] [Full Text] [PDF]

				R. W. Mankhey, C. C. Wells, F. Bhatti, and C. Maric 17beta-Estradiol supplementation reduces tubulointerstitial fibrosis by increasing MMP activity in the diabetic kidney Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R769 - R777. [Abstract] [Full Text] [PDF]

				A. Thawornkaiwong, J. Pantharanontaga, and J. Wattanapermpool Hypersensitivity of myofilament response to Ca2+ in association with maladaptation of estrogen-deficient heart under diabetes complication Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R844 - R851. [Abstract] [Full Text] [PDF]